Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0370 per EA under NDC 75834025701. Its NADAC has been published 299 times since Dec 2, 2020.
FDA first approved this application on Aug 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Atorvastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834025701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA213853FDA Approved
8/19/2020
TE Code
AB
On Market Since
8/26/2020
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 299 times since Dec 2, 2020, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0370 per EA |
|---|---|
| All-time high | $0.0789 (Jan 13, 2021) |
| All-time low | $0.0370 (Aug 19, 2026) |
| 52-week high | $0.0449 |
| 52-week low | $0.0370 |
| Median price | $0.0568 |
| Average price | $0.0556 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 299 |
| Tracking since | Dec 2, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0370 per EA (NDC 75834025701), effective Aug 19, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 51.8%. It has been tracked across 299 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Dec 2, 2020, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0370 (Aug 19, 2026) to a high of $0.0789 (Jan 13, 2021), with a median of $0.0568 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 75834025701) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.